Beiträge

Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy

Poster presentation at the annual meeting of the Association for Cancer Immunotherapy

Poster presentation at the International Symposium on Pediatric Neuro-Oncology

Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors

DNA methylation based glioblastoma subclassification is related to tumoral T-cell infiltration and patient survival

Impaired DNA repair in mouse monocytes compared to macrophages and precursors

Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged

Evidence-Based Medicine in Oncology: Commercial Versus Patient Benefit